Domicilium Real Estate Fund III (ELOX) details Eloxx stock and warrant stakes
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Domicilium Real Estate Fund III LP filed an initial ownership report for Eloxx Pharmaceuticals, Inc. as a greater-than-10% holder. The filing shows indirect ownership of 14,285 shares of Eloxx common stock.
The fund also indirectly holds several Pre-Funded Warrants to purchase Eloxx common stock, with underlying share amounts of 611,317, 361,578, 1,196,067 and 238,422 shares. These warrants are exercisable at an exercise price of $0.1100 per share and have no expiration date. A footnote states that holders may not exercise Pre-Funded Warrants if, after exercise, they would beneficially own more than 19.99% of Eloxx’s outstanding common stock.
The securities are held through entities including Domicilium Real Estate Fund III LP, BKJLAGG, LLC, MSEK Charleston LLC and Bold Stroke Investments, LLC, and may be deemed indirectly beneficially owned by Domicilium Capital Partners LLC, its affiliates and Daniel Simon.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Domicilium Real Estate Fund III LP
Role
10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Pre-funded Warrant | -- | -- | -- |
| holding | Pre-funded Warrant | -- | -- | -- |
| holding | Pre-funded Warrant | -- | -- | -- |
| holding | Pre-funded Warrant | -- | -- | -- |
| holding | common stock, $0.01 par value per share | -- | -- | -- |
Holdings After Transaction:
Pre-funded Warrant — 238,422 shares (Indirect, See footnote);
common stock, $0.01 par value per share — 14,285 shares (Indirect, See footnote)
Footnotes (1)
- The securities may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium"), and (ii) Daniel Simon, the managing member of Domicilium. The pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise. The securities are owned directly by Domicilium Real Estate Fund III LP (the "Fund") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (ii) Daniel Simon, the managing member of Domicilium and the General Partner. The securities are owned directly by BKJLAGG, LLC ("BKJLAGG") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to BKJLAGG, and (ii) Daniel Simon, the managing member of Domicilium. The securities are owned directly by MSEK Charleston LLC ("MSEK") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to MSEK, and (ii) Daniel Simon, the managing member of Domicilium. The securities are owned directly by Bold Stroke Investments, LLC ("Bold Stroke") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to Bold Stroke, and (ii) Daniel Simon, the managing member of Domicilium.
Key Figures
Common shares owned: 14,285 shares
Pre-Funded Warrant underlying shares: 611,317 shares
Pre-Funded Warrant underlying shares: 361,578 shares
+4 more
7 metrics
Common shares owned
14,285 shares
Indirect common stock holdings reported on Form 3
Pre-Funded Warrant underlying shares
611,317 shares
Underlying Eloxx common stock for one warrant position
Pre-Funded Warrant underlying shares
361,578 shares
Underlying Eloxx common stock for one warrant position
Pre-Funded Warrant underlying shares
1,196,067 shares
Underlying Eloxx common stock for one warrant position
Pre-Funded Warrant underlying shares
238,422 shares
Underlying Eloxx common stock for one warrant position
Warrant exercise price
$0.1100 per share
Exercise price of Pre-Funded Warrants for Eloxx common stock
Beneficial ownership cap
19.99%
Maximum beneficial ownership allowed after warrant exercise
Key Terms
Pre-Funded Warrants, indirectly beneficially owned, beneficially own more than 19.99%, investment adviser, +1 more
5 terms
Pre-Funded Warrants financial
"The pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") have no expiration date"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
indirectly beneficially owned financial
"The securities may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC"
beneficially own more than 19.99% regulatory
"A holder of Pre-Funded Warrants may not exercise ... if the holder ... would beneficially own more than 19.99% of the number of shares"
investment adviser financial
"Domicilium, the investment adviser to the Fund"
An investment adviser is a person or firm that professionally manages money and gives recommendations about buying, selling, or holding investments. Like a financial coach or guide, they have a legal duty to act in a client's best financial interest, so their advice, fees and potential conflicts can directly affect returns and risk — making their role important for investors who want informed, accountable help with portfolios.
general partner financial
"Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund"
A general partner is the person or firm that runs an investment partnership and legally represents it — they make the day-to-day decisions, choose which assets to buy or sell, and are responsible for the partnership’s obligations. Investors care because the general partner’s judgment, risk-taking and fee and profit-sharing arrangements determine both the potential returns and the level of exposure to losses; think of the GP as the ship’s captain whose skill and honesty shape the voyage’s outcome.
FAQ
What does the Domicilium Real Estate Fund III LP Form 3 for ELOX report?
The Form 3 reports Domicilium Real Estate Fund III LP’s initial beneficial ownership in Eloxx Pharmaceuticals. It details indirect holdings of common stock and multiple Pre-Funded Warrants, outlining share amounts, exercise price, and a 19.99% ownership cap on warrant exercises.
What Pre-Funded Warrants are disclosed in the Domicilium Form 3 for Eloxx (ELOX)?
The filing shows several Pre-Funded Warrants with underlying share amounts of 611,317, 361,578, 1,196,067 and 238,422 Eloxx common shares. Each warrant series is exercisable at $0.1100 per share, providing significant potential equity exposure if fully exercised within ownership limits.
What is the exercise price of the Pre-Funded Warrants reported for Eloxx (ELOX)?
Each Pre-Funded Warrant disclosed in the filing has an exercise price of $0.1100 per share. This means holders can acquire Eloxx common stock at $0.1100 per share upon exercise, subject to the beneficial ownership limitation described in the Form 3 footnotes.
Do the Eloxx (ELOX) Pre-Funded Warrants reported by Domicilium have an expiration date?
The footnotes state the Pre-Funded Warrants have no expiration date and are exercisable at any time after issuance. This gives the holders ongoing flexibility to convert the warrants into Eloxx common shares, subject to the 19.99% beneficial ownership restriction.
What is the 19.99% beneficial ownership limitation mentioned in the Eloxx (ELOX) Form 3?
The Form 3 states a Pre-Funded Warrant holder cannot exercise if, after exercise, it and its affiliates would beneficially own more than 19.99% of Eloxx’s outstanding common stock. This cap limits how much of the company can be held via warrant exercises.